---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-23-001389"
form_type: "8-K"
ticker: "LIPO"
cik: "0001347242"
company_name: "LIPELLA PHARMACEUTICALS INC."
filed_at: "2023-10-26T23:59:59+00:00"
generated_at: "2026-06-09T08:15:46.208931+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Lipella raises $2M via private placement of pre-funded warrants and warrants

## Summary
- Gross proceeds ~$2M from sale of 1,315,790 pre-funded warrants (exercise $0.001) and 1,315,790 warrants (exercise $1.40) at $1.519/unit.
- Warrants immediately exercisable, expire in 3 years; exercise price $1.40 per share.
- H.C. Wainwright acted as exclusive placement agent; received 7.5% cash fee, 1% mgmt fee, $50k expense allowance, and 98,684 placement agent warrants.
- Company agreed to file resale registration statement within 7 business days, effective within 45-75 calendar days.
- Net proceeds intended for working capital and general corporate purposes.

## SEC filing metadata
- accession: 0001753926-23-001389
- form_type: 8-K
- ticker: LIPO
- cik: 0001347242
- company_name: LIPELLA PHARMACEUTICALS INC.
- filed_at: 2023-10-26T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1347242/000175392623001389/0001753926-23-001389-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1347242/000175392623001389/g083821_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-23-001389
- JSON: https://secwatch.observer/filing/0001753926-23-001389.json
- Plain text: https://secwatch.observer/filing/0001753926-23-001389.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.